Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism PKM2 inhibitors(Pyruvate kinase isozymes M1/M2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Lung Cancer | Preclinical | India | 01 Jan 2024 |